Magnetar Financial LLC Bausch Health Companies Inc. Transaction History

Magnetar Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$6.28 - $9.85 $1.14 Million - $1.8 Million	-182,317 Reduced 68.6%	83,462 $676,000
Q4 2022 Feb 14, 2023	BUY	$6.09 - $7.93 $829,025 - $1.08 Million	136,129 Added 105.0%	265,779 $1.67 Million
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $92,886 - $186,788	20,281 Added 18.54%	129,650 $893,000
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $772,145 - $2.58 Million	109,369 New	109,369 $914,000
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $8.02 Million - $10.3 Million	-371,295 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $8.54 Million - $10.8 Million	371,295 New	371,295 $10.3 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.